Seenu Hariprasad to Drug Implants
This is a "connection" page, showing publications Seenu Hariprasad has written about Drug Implants.
Connection Strength
0.607
-
Discontinuous to continuous therapy for persistent diabetic macular edema leads to reduction in treatment frequency. Eur J Ophthalmol. 2021 Mar; 31(2):612-619.
Score: 0.174
-
Long-term outcomes after intravitreal dexamethasone treatment in steroid responders. Acta Diabetol. 2019 Jun; 56(6):675-680.
Score: 0.163
-
Controversies in the management of Irvine-Gass syndrome. Ophthalmic Surg Lasers Imaging Retina. 2013 Nov 01; 44(6):522-7.
Score: 0.113
-
The 0.19-mg Fluocinolone Acetonide Implant for the Treatment of Diabetic Macular Edema: An Expert Consensus. Ophthalmic Surg Lasers Imaging Retina. 2023 03; 54(3):166-173.
Score: 0.054
-
Dexamethasone and Anti-VEGF Combination Therapy for the Treatment of Diabetic Macular Edema. Ophthalmic Surg Lasers Imaging Retina. 2019 01 01; 50(1):4-7.
Score: 0.040
-
Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome. Am J Ophthalmol. 2017 Dec; 184:121-128.
Score: 0.037
-
Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema. Ophthalmology. 2012 Oct; 119(10):2125-32.
Score: 0.026